Role of fluticasone propionate in modern treatment of allergic rhinitis

Cover Page

Cite item

Full Text

Abstract

Allergic rhinitis is a common disease that greatly affect a quality of life and can contribute to the development of concomitant pathology of the upper airway tract. The main aim of the treatment is reducing or riddance of symptoms, prevention of acute conditions and complications. Appropriate treatment should allow patients to keep their normal pattern of life. Intranasal corticosteroids is the first-line treatment considering allergic rhinitis. According to multitude investigations fluticasone propionate proved its effectiveness in a control of the symptoms of allergic rhinitis along with low incidence of side effects.

About the authors

V. M Svistushkin

I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

Email: svvm3@yandex.ru
д-р мед. наук, проф., дир. клиники, зав. каф. болезней уха, горла и носа 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

P. A Kochetkov

I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

Email: adenotom@yandex.ru
канд. мед. наук, доц. каф. болезней уха, горла и носа 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

E. S Shchennikova

I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

врач-оториноларинголог 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

O. Yu Karpova

I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

д-р мед. наук, проф. 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

References

  1. Dykewicz M.S, Hamilos D.L. Rhinitis and sinusitis. J Allergy Clin Immunol 2010; 125: 103-15.
  2. Brożek J.L, Bousquet J, Agachee I et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Guidelines - 2016 Revision. J Allergy Clin Immunol 2017; 140 (6).
  3. Janson C, Johannessen A, Franklin K et al. Change in the prevalence asthma, rhinitis and respiratory symptom over a 20 year period: associations to year of birth, life style and sleep related symptoms 2018. doi: 10.1186/s12890-018-0690-9
  4. Meltzer E.O. Allergic rhinitis: burden of illness, quality of life, comorbidities, and control. Immunol Allergy Clin North Am 2016; 36 (2): 235-48.
  5. Meltzer E.O, Blaiss M.S, Naclerio R.M et al. Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys. Allergy Asthma Proc 2012; 33 (5): 113-41.
  6. Roxbury C.R, Qiu M, Shargorodsky J. Association between allergic rhinitis and poor sleep parameters in US adults. Int Forum Allergy Rhinol 2018; 8 (10): 1098-106.
  7. Robinson S, Buchs S, Hammerby E et al. A Review of The Quality of Life and Educational Burden of Allergic Rhinitis on Adolescents. Value Health 2017; 20 (9): 648.
  8. Павлова К.С. Аллергический ринит. Мед. совет. 2013; 1: 89-96.
  9. Vlastos I, Athanasopoulos I, Mastronikolis N.S et al. Impaired mucociliary clearance in allergic rhinitis patients is related to a predisposition to rhinosinusitis. Ear Nose Throat J 2009; 88 (4): 17-9.
  10. Kreiner-Moller E, Chawes B.L, Caye-Thomasen P et al. Allergic rhinitis is associated with otitis media with effusion: a birth cohort study. Clin Exp Allergy 2012; 42 (11): 1615-20.
  11. Luong A, Roland P.S. The link between allergic rhinitis and chronic otitis media with effusion in atopic patients. Otolaryngol Clin North Am 2008; 41 (2): 311-23.
  12. Морозова С.В., Карапетян Л.С. Актуальная гипосенсибилизирующая терапия аллергического ринита. Мед. совет. 2018; 8: 76-9. / Morozova S.V., Karapetian L.S. Aktual'naia giposensibiliziruiushchaia terapiia allergicheskogo rinita. Med. sovet. 2018; 8: 76-9. [in Russian]
  13. Platts-Mills T.A, Vervloet D, Thomas W.R et al. Indoor allergens and asthma: report of the Third International Workshop. J Allergy Clin Immunol 1997; 100 (6): 2-24.
  14. Piacentini G.L, Martinati L, Mingoni S, Boner A.L. Influence of allergen avoidance on the eosinophil phase of airway inflammation in children with allergic asthma. J Allergy Clin Immunol 1996; 97 (5): 1079-84.
  15. Sharma H.P, Hansel N.N, Matsui E et al. Indoor environmental influences on children's asthma. Pediatr Clin North Am 2007; 54 (1): 103-20.
  16. Platts-Mills T.A. Allergen avoidance in the treatment of asthma and allergic rhinitis. UpToDate Updated October 2016.
  17. Maloney J, Bernstein D.I, Nelson H et al. Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial. Ann Allergy Asthma Immunol 2014; 112: 146-53.
  18. Creticos P.S, Maloney J, Bernstein D.I et al. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults. J Allergy Clin Immunol 2013; 131: 1342-9.
  19. Wheatley L.M, Togias A. Allergic rhinitis. N Engl J Med 2015; 372 (5): 456-63.
  20. Wallace D.V, Dykewicz M.S, Bernstein D.I et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008; 122: 1-84.
  21. Small P, Kim H. Allergic rhinitis. Allergy Asthma Clin Immunol 2011; 7 (1): 3.
  22. Yanez A, Rodrigo G.J. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2002; 896: 479-84.
  23. Wallace D.V, Dykewicz M.S, Bernstein D.I et al. J Allergy Clin Immunol 2008; 122 (2): 1-84.
  24. Pullerits T, Praks L, Ristioja V et al. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 2002; 109: 949-55.
  25. Weiner J.M, Abramson M.J, Puy R.M. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998; 317: 1624-9.
  26. Biggadike K. Fluticasone furoate/fluticasone propionate - different drugs with different properties. Clin Respiratory J 2011; 5 (3): 183-4.
  27. Ильина Н.И., Козлов В.С., Павлова К.С. и др. Опыт применения флутиказона пропионата у пациентов с аллергическим ринитом в России. Болезни органов дыхания (Прил. к журн. Consilium Medicum). 2008; 1: 58-61. / Il'ina N.I., Kozlov V.S., Pavlova K.S. i dr. Opyt primeneniia flutikazona propionata u patsientov s allergicheskim rinitom v Rossii. Respiratory Organs Diseases (Suppl. Consilium Medicum). 2008; 1: 58-61. [in Russian]
  28. Carr W.W, Ratner P, Munzel U et al. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis. Allergy Asthma Proc 2012; 33 (6): 45-9.
  29. Small P, Frenkiel S, Becker A et al. The Canadian Rhinitis Working Group: Rhinitis: A practical and comprehensive approach to assessment and therapy. J Otolaryngol 2007; 36 (1): 5-27.
  30. Sastre J, Mosges R. Local and systemic safety of intranasal corticosteroids. J Investig Allergol Clin Immunol 2012; 22: 1-12.
  31. Allen D.B, Meltzer E.O, Lemanske R.F.Jr. et al. No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc 2002; 23: 407-13.
  32. Groupa F.P. Fluticasone Propionate Collaborative Pediatric Working Group. Treatment of seasonal allergic rhinitis with once-daily intranasal fluticasone propionate therapy in children. J Pediatr 1994; 125: 628-34.
  33. Bernstein D.I, Levy A.L, Hampel F.C et al. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis. Clin Exp Allergy 2004; 34: 952-7.
  34. Ratner P, Van Bavel J, Mohar D et al. Efficacy of daily intranasal fluticasone propionate on ocular symptoms associated with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2015; 114 (2): 141-7.
  35. Hadley J.A, Derebery J.M, Marple B.F. Comorbidities and allergic rhinitis: not just a runny nose. J Fam Pract 2012; 61 (2): 11-5.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).